Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dayer

Showing results (31-40 of 163) with videos related to

Pageof 17
Sort By:
European Journal of Clinical Pharmacology|January 1, 1996
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicamP Bonnabry, T Leemann, P Dayer
La Revue Du Praticien|June 21, 1980
[Diffusion and metabolism of drugs in renal insufficiency]J Fabre, P Dayer, L Balant
Life Sciences|January 1, 1992
In vitro oxidation of oxicam NSAIDS by a human liver cytochrome P450J Zhao, T Leemann, P Dayer
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 28, 1976
[Drug compendia in Switzerland (authors transl)]P Schulz, M Casthelaz, P Dayer
Pharmacogenetics|April 1, 1997
Lung cancer risk in relation to mephenytoin hydroxylation activityS Benhamou, C Bouchardy, P Dayer
Drugs|January 1, 1994
The pharmacology of tramadolP Dayer, L Collart, J Desmeules
Life Sciences|January 1, 1993
Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liverT Leemann, C Transon, P Dayer
Carcinogenesis|April 3, 1998
Re: London,S.J. et al. (1997) Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis, 18, 1203-1214C Bouchardy, S Benhamou, P Dayer
Cancer Research|January 15, 1996
The effect of tobacco on lung cancer risk depends on CYP2D6 activityC Bouchardy, S Benhamou, P Dayer
Schweizerische Medizinische Wochenschrift|December 16, 1989
[Drug interactions of midazolam]M P Gascon, P Dayer, F Waldvogel
Pageof 17

Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Clinical Pharmacology|January 1, 1996
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicamP Bonnabry, T Leemann, P Dayer
La Revue Du Praticien|June 21, 1980
[Diffusion and metabolism of drugs in renal insufficiency]J Fabre, P Dayer, L Balant
Life Sciences|January 1, 1992
In vitro oxidation of oxicam NSAIDS by a human liver cytochrome P450J Zhao, T Leemann, P Dayer
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 28, 1976
[Drug compendia in Switzerland (authors transl)]P Schulz, M Casthelaz, P Dayer
Pharmacogenetics|April 1, 1997
Lung cancer risk in relation to mephenytoin hydroxylation activityS Benhamou, C Bouchardy, P Dayer
Drugs|January 1, 1994
The pharmacology of tramadolP Dayer, L Collart, J Desmeules
Life Sciences|January 1, 1993
Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liverT Leemann, C Transon, P Dayer
Carcinogenesis|April 3, 1998
Re: London,S.J. et al. (1997) Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis, 18, 1203-1214C Bouchardy, S Benhamou, P Dayer
Cancer Research|January 15, 1996
The effect of tobacco on lung cancer risk depends on CYP2D6 activityC Bouchardy, S Benhamou, P Dayer
Schweizerische Medizinische Wochenschrift|December 16, 1989
[Drug interactions of midazolam]M P Gascon, P Dayer, F Waldvogel
Pageof 17